STAND. COM. REP. NO. 1020

Honolulu, Hawaii

, 2005

RE: H.C.R. No. 36

H.D. 1

 

 

 

Honorable Calvin K.Y. Say

Speaker, House of Representatives

Twenty-Third State Legislature

Regular Session of 2005

State of Hawaii

Sir:

Your Committee on Health, to which was referred H.C.R. No. 36 entitled:

"HOUSE CONCURRENT RESOLUTION REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND FINANCIAL EFFECTS OF REQUIRING HEALTH INSURERS TO OFFER COVERAGE FOR THE EARLY DETECTION OF PROSTATE CANCER IN ACCORDANCE WITH THE PROSTATE CANCER EARLY DETECTION GUIDELINES OF THE NATIONAL COMPREHENSIVE CANCER NETWORK,"

begs leave to report as follows:

The purpose of this concurrent resolution is to request the Auditor perform a study on the social and financial implications of requiring health insurers to offer coverage of medical procedures for the early detection of prostate cancer.

The American Cancer Society, Hawaii Medical Service Association, National Prostate Cancer Coalition, and a concerned individual supported this concurrent resolution. Kaiser Permanente supported the intent of this measure.

Your Committee finds that early detection of prostate cancer is vital to preventing its debilitating and deadly effects by setting into motion the appropriate treatment regimen at the earliest possible time and thereby increasing the chances of a full recovery for those afflicted by this disease.

 

In an effort to more fully address this concern, your Committee has amended this concurrent resolution by:

(1) Adding the prostate cancer early detection guidelines of

the:

(A) American Academy of Family Physicians;

(B) American Cancer Society;

(C) American Urological Association, Inc.;

(D) Centers for Disease Control; and

(E) United States Preventive Services Task Force;

(2) Changing the title of the concurrent resolution to read:

"REQUESTING THE AUDITOR TO ASSESS THE SOCIAL AND

FINANCIAL EFFECTS OF REQUIRING HEALTH INSURERS TO OFFER COVERAGE FOR THE EARLY DETECTION OF PROSTATE CANCER IN ACCORDANCE WITH NATIONALLY RECOGNIZED AND ACCEPTED PROSTATE CANCER EARLY DETECTION GUIDELINES"; and

(3) Making technical, nonsubstantive changes for clarity,

consistency, and style.

As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee concurs with the intent and purpose of H.C.R. No. 36, as amended herein, and recommends that it be referred to the Committee on Consumer Protection & Commerce in the form attached hereto as H.C.R. No. 36, H.D. 1.

 

Respectfully submitted on behalf of the members of the Committee on Health,

 

____________________________

DENNIS A. ARAKAKI, Chair